Drug Shortage Report for MAR-ATORVASTATIN

Last updated on 2019-12-11 History
Report ID 98775
Drug Identification Number 02454025
Brand name MAR-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name MARCAN PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 TABLET
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-11-14
Actual start date 2019-11-14
Estimated end date 2019-12-10
Actual end date 2019-12-10
Shortage status Resolved
Updated date 2019-12-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-12-11 English Compare
v8 2019-12-10 French Compare
v7 2019-12-10 English Compare
v6 2019-12-09 French Compare
v5 2019-12-09 English Compare
v4 2019-12-02 French Compare
v3 2019-12-02 English Compare
v2 2019-11-15 French Compare
v1 2019-11-15 English Compare

Showing 1 to 9 of 9